Brief: OncoTherapy Science says business and capital alliance with Theragen Etex

THERAGEN ETEX CO

12/07/2017 06:40

July 12 (Reuters) - OncoTherapy Science Inc  4564.T  
     
     
    * Says it will establish a wholly owened subsidary on July 
24 
    * Say it will transfer research and development of cancer 
immunotherapy related business to the subsidiary, effective Nov. 
1  
    * The subsidary will issue 150 new shares to Theragen Etex 
Co., Ltd.  066700.KQ , at the price of 1 million yen per share, 
or 150 million yen in total, and payment date on Aug. 7  
    * Theragen Etex Co., Ltd. will acquire 310 shares of the 
subsidiary, at the price of 1 million yen, for 310 million yen 
in total, from the co, effective Nov. 15  
    * Say the co and Theragen Etex Co., Ltd. Will hold a 64 
percent stake and a 36 percent stake finally  
 
     
    Source text in Japanese:https://goo.gl/W6DAhV 
    Further company coverage: 4564.T  066700.KQ  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111; 
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))